AXIM Biotechnologies is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products as well as alternative sources of energy. We prioritize the well being of our customers while embracing a solid fiscal strategy. We believe to be setting the green standard for cannabinoid bioscience through the discovery and commercialization of new materials and technologies for healthy living, all while respecting the environment.
Quote | Axim Biotechnologies Inc (OTCMKTS:AXIM)
Last: | $0.0148 |
---|---|
Change Percent: | 20.82% |
Open: | $0.0133 |
Close: | $0.01225 |
High: | $0.0149 |
Low: | $0.0133 |
Volume: | 92,754 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Axim Biotechnologies Inc (OTCMKTS:AXIM)
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA - ( NewMediaWire ) - March 27, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,...
The Company’s Commercialization Partner Verséa Ophthalmic Places Re-stock Order of AXIM’s Digital Assay Reader SAN DIEGO, CA - ( NewMediaWire ) - February 20, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,” ...
Message Board Posts | Axim Biotechnologies Inc (OTCMKTS:AXIM)
Subject | By | Source | When |
---|---|---|---|
Lots of people go out for lunch even | Blue Skys | investorshub | 04/27/2023 7:34:23 PM |
My apologies. The "Headshots Lounge" provides | TexasMarvL | investorshub | 04/26/2023 11:23:07 PM |
Yes! Very near the front entrance and | TexasMarvL | investorshub | 04/26/2023 10:57:46 PM |
That is a solid observation. The booth | Blue Skys | investorshub | 04/26/2023 9:42:28 PM |
I asked the surgeon who installed my IOL's | Blue Skys | investorshub | 04/26/2023 9:26:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Axim Biotechnologies Inc Company Name:
AXIM Stock Symbol:
OTCMKTS Market:
Axim Biotechnologies Inc Website:
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM's Diagnostic Research Programs in Dry Eye Disease and Parkinson's SAN DI...
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA - ( NewMediaWire ) - March 27, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,...
The Company’s Commercialization Partner Verséa Ophthalmic Places Re-stock Order of AXIM’s Digital Assay Reader SAN DIEGO, CA - ( NewMediaWire ) - February 20, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,” ...